12:00 AM
 | 
Dec 11, 2000
 |  BC Week In Review  |  Company News  |  Other News

AVI other research news

AVII said that a Neugene antisense compound against TGF-beta accelerated engraftment of transplanted treated hematopoietic stem cells and reduced the number of stem cells...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >